Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

Patrick N. A. Harris(The University of Queensland), David L. Paterson(The University of Queensland), Amy Crowe(St Vincent's Hospital Melbourne), Nick Daneman(Institute of Health Services and Policy Research), Thamer H. Alenazi(King Saud bin Abdulaziz University for Health Sciences), Tom Boyles(Groote Schuur Hospital), Yin Mo(National University of Singapore), Yaseen M. Arabi(World Health Organization), Penelope Lorenc(The University of Queensland), Souha S. Kanj(American University of Beirut Medical Center), Paul R. Ingram(Fiona Stanley Hospital), Matteo Bassetti(Ospedale Policlinico San Martino), David Chien Lye(Agency for Science, Technology and Research), Benjamin A. Rogers(Monash University), Genevieve Walls(Middlemore Hospital), Paul Anantharajah Tambyah(National University of Singapore), Marc Mendelson(University of Cape Town), Marco Falcone, David Looke(The University of Queensland), Jonathan R. Iredell(The University of Sydney), Tau H. Lee(Tan Tock Seng Hospital), Hasan Bhally(North Shore Hospital), Elda Righi(Ospedale Santa Maria della Misericordia di Udine), Mesut Yılmaz(Inonu University), Paul Griffin(The University of Queensland), Leah W. Roberts(The University of Queensland), Ahmed Zikri(King Fahad Specialist Hospital), Eugene Athan(Barwon Health), Scott A. Beatson(The University of Queensland), Peter Baker(The University of Queensland), Anton Y. Peleg(Monash University), Tiffany Harris‐Brown(The University of Queensland), Mohammed Al Khamis(King Fahad Specialist Hospital), Spiros Miyakis(UNSW Sydney)
JAMA
September 11, 2018
Cited by 761


Related Papers